Chemoenzymatic synthesis of novel cytotoxic epoxyketones using the eponemycin biosynthetic enzyme EpnF Journal Article


Authors: Corless, B. C.; Geißen, R.; Prescott, N. A.; David, Y.; Scheinberg, D. A.; Tan, D. S.
Article Title: Chemoenzymatic synthesis of novel cytotoxic epoxyketones using the eponemycin biosynthetic enzyme EpnF
Abstract: Eponemycin is an alpha,beta-epoxyketone naturalproduct thatinhibits the proteasome via covalent interactionof the epoxyketone warhead with catalytic N-terminal threonine residues.The epoxyketone warhead is biosynthesized from a beta-ketoacidsubstrate by EpnF, a recently identified flavin-dependent acyl-CoAdehydrogenase-like enyzme. Herein, we report biochemical characterizationof EpnF kinetics and substrate scope using a series of synthetic beta-ketoacidsubstrates. These studies indicate that epoxide formation likely occursprior to other tailoring reactions in the biosynthetic pathway, andhave led to the identification of novel epoxyketone analogues withpotent anticancer activity.
Keywords: carfilzomib; proteasome inhibitors; epoxomicin; warhead
Journal Title: ACS Chemical Biology
Volume: 18
Issue: 6
ISSN: 1554-8929
Publisher: American Chemical Society  
Date Published: 2023-06-16
Start Page: 1360
End Page: 1367
Language: English
ACCESSION: WOS:001010996400001
DOI: 10.1021/acschembio.3c00080
PROVIDER: wos
PUBMED: 37172287
PMCID: PMC10358350
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Derek S. Tan -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Derek S Tan
    91 Tan